EASL Campus

Skip to main content

Login

User menu

Mega menu

EASL.eu
Resources
Resources
- EASL Resources
- EASL-Related Resources
- Industry Resources
- Patient Resources
EASL Studio
EASL Campus Connect
- My Community
- Explore Community
- Create
Our Sponsors

Keywords

Options

Items per page

Industry Topics

Show all (13) (-) Show all (13)
Metabolism, Alcohol & Toxicity (8) Metabolism, Alcohol & Toxicity (8)
Viral Hepatitis (5) Viral Hepatitis (5)

Industry Resource Type

Show all (13) (-) Show all (13)
Webcasts (13) Webcasts (13)

Industry Congress resources

Show all (13) (-) Show all (13)
EASL Congress 2024 (13) EASL Congress 2024 (13)

Industry Language

Show all (8) (-) Show all (8)
English (8) English (8)

Year

Show all (36) Show all (36)
2020 (5) 2020 (5)
2021 (5) 2021 (5)
2022 (6) 2022 (6)
2023 (2) 2023 (2)
2024 (13) (-) 2024 (13)
2025 (5) 2025 (5)

Show all (101) Show all (101)
AbbVie (6) AbbVie (6)
Advanz Pharma (4) Advanz Pharma (4)
AKH (6) AKH (6)
AstraZeneca (6) AstraZeneca (6)
Bayer (6) Bayer (6)
Biotest (5) (-) Biotest (5)
Boehringer Ingelheim (11) Boehringer Ingelheim (11)
CymaBay (10) CymaBay (10)
Grifols (4) Grifols (4)
GSK (4) GSK (4)
Ipsen (5) Ipsen (5)
Mirum Pharmaceuticals Inc (9) Mirum Pharmaceuticals Inc (9)
Novo Nordisk (8) (-) Novo Nordisk (8)
Opella (8) Opella (8)
Roche (4) Roche (4)
Takeda (5) Takeda (5)

Primary tabs

User menu

Resources 13
Session 13 (current)

Displaying 13 - 13 of 13

Display:

Metabolism, Alcohol & Toxicity

5

Novo Nordisk: Unfolding the metabolic dysfunction of MASH: exploring the pathophysiology and outcomes - EASL Congress 2024

View

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 13 - 13 of 13

Display:

Community Stream

Easl Community Feed My Feed

Home of Hepatology
7 rue Daubin
1203 Geneva
Switzerland

Follow us:

Sign up to EASL News

©2019 - EASL. All Rights Reserved. Powered by Enovation.

Footer menu

Content Access policy
Privacy Policy
Cookie Policy